NOSU
NOTICE OF SUIT
02/28/2023
Back to search
Official data from USPTO
ASPERCREME
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
ASPERCREME
ST13
US500000072379712Class
5, 18
Filing
72379712
Registration
933107
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
19
Latest update
02/28/2023
Trademark type
Word
Nice classes
5, 18
Filing date
12/28/1970
Registration date
05/02/1972
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
10/12/2022
Last transaction
11/04/2022
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
First use anywhere
10/12/1970
First use in commerce
11/09/1970
Drawing code
1
Owner type
03
Owner location
CHATTANOOGA, TN
Current location
GENERIC WEB UPDATE
Holders and representatives
Holders
CHATTEM, INC.
SIGNAL INVESTMENT & MANAGEMENT, CO
THOMPSON MEDICAL COMPANY, INC.
SPERTI DRUG PRODUCTS, INC., THE
Representatives
Victoria Friedman Dennemeyer & Associates, LLC
Technical classification
Nice Classes
Class 5Class 18
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
No specification.
Class 18
ANALGESIC CREAM FOR TOPICAL APPLICATION
Publications
History of USPTO decisions and trademark events.
19 publications found
NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
10/12/2022
RNL3
REGISTERED AND RENEWED (THIRD RENEWAL - 10 YRS)
10/12/2022
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
10/12/2022
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
10/12/2022
E89R
TEAS SECTION 8 & 9 RECEIVED
04/14/2022
NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - MAILED
05/09/2012
RNL2
REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)
05/09/2012
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
05/09/2012
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
05/09/2012
E89R
TEAS SECTION 8 & 9 RECEIVED
04/25/2012
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
01/11/2012
CFIT
CASE FILE IN TICRS
09/05/2008
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
09/13/2001
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
09/13/2001
89AF
REGISTERED - COMBINED SECTION 8 (10-YR) & SEC. 9 FILED
06/18/2001
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
02/11/1992
9.AF
REGISTERED - SEC. 9 FILED/CHECK RECORD FOR SEC. 8
01/23/1992
8.OK
REGISTERED - SEC. 8 (6-YR) ACCEPTED
09/12/1977
Continuous trademark protection
Get notified about every new filing that threatens ASPERCREME or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.